Gain on sale of assets after tax

No definition available.

Name:	jnj_Gainonsaleofassetsaftertax
Namespace Prefix:	jnj_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Integration costs after tax

+ References

No definition available.

+ Details

Name:	jnj_Integrationcostsaftertax
Namespace Prefix:	jnj_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Integration/transaction costs and currency related to a Business Acquisition.

+ References

No definition available.

+ Details

Name:	jnj_IntegrationTransactionCostsAndCurrencyRelatedToBusinessAcquisition
Namespace Prefix:	jnj_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Litigation And Recall Expense.

+ References

No definition available.

+ Details

Name:	jnj_LitigationAndRecallExpense
Namespace Prefix:	jnj_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Litigation expense net after tax.

+ References

No definition available.

+ Details

Name:	jnj_LitigationExpenseNetAfterTax
Namespace Prefix:	jnj_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Recall costs after tax.

+ References

No definition available.

+ Details

Name:	jnj_RecallCostsAfterTax
Namespace Prefix:	jnj_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

research and development after tax

+ References

No definition available.

+ Details

Name:	jnj_Researchanddevelopmentaftertax
Namespace Prefix:	jnj_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Details

Name:	jnj_SelectedQuarterlyFinancialDataUnauditedTextualAbstract
Namespace Prefix:	jnj_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=8077374&loc=d3e2420-110228

+ Details

Name:	us-gaap_AssetImpairmentCharges
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Amount of gain (loss) from the difference between the sale price or salvage price and the book value of an asset that was sold or retired, and gain (loss) from the write down of assets from their carrying value to fair value.

+ References

No definition available.

+ Details

Name:	us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.

+ References

No definition available.

+ Details

Name:	us-gaap_LitigationSettlementExpense
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Other expenses directly related to the marketing or selling of products or services not otherwise defined.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.4)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name:	us-gaap_OtherSellingAndMarketingExpense
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Amount of other income tax expense (benefit).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph h

-Article 4

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 9

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 10

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32672-109319

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(h)(1))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

+ Details

Name:	us-gaap_OtherTaxExpenseBenefit
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

The amount of purchased research and development assets that are acquired in a business combination have no alternative future use and are therefore written off in the period of acquisition.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 730

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373

+ Details

Name:	us-gaap_ResearchAndDevelopmentInProcess
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Details

Name:	us-gaap_SelectedQuarterlyFinancialInformationAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

Selected Quarterly Financial Data (Unaudited) (Details Textual) (USD $)	3 Months Ended								12 Months Ended
	Dec. 28, 2014	Sep. 28, 2014	Jun. 29, 2014	Mar. 30, 2014	Dec. 29, 2013	Sep. 29, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 28, 2014	Dec. 29, 2013	Dec. 30, 2012
Selected Quarterly Financial Information [Abstract]
Integration costs after tax	$ 237,000,000jnj_Integrationcostsaftertax	$ 130,000,000jnj_Integrationcostsaftertax	$ 104,000,000jnj_Integrationcostsaftertax	$ 84,000,000jnj_Integrationcostsaftertax	$ 110,000,000jnj_Integrationcostsaftertax	$ 103,000,000jnj_Integrationcostsaftertax	$ 87,000,000jnj_Integrationcostsaftertax	$ 183,000,000jnj_Integrationcostsaftertax
Selected Quarterly Financial Data Unaudited (Textual) [Abstract]
Litigation income expense net after-tax	652,000,000jnj_LitigationExpenseNetAfterTax	231,000,000jnj_LitigationExpenseNetAfterTax	342,000,000jnj_LitigationExpenseNetAfterTax		227,000,000jnj_LitigationExpenseNetAfterTax	720,000,000jnj_LitigationExpenseNetAfterTax	308,000,000jnj_LitigationExpenseNetAfterTax	391,000,000jnj_LitigationExpenseNetAfterTax
Litigation Settlement, Expense	692,000,000us-gaap_LitigationSettlementExpense	285,000,000us-gaap_LitigationSettlementExpense	276,000,000us-gaap_LitigationSettlementExpense		506,000,000us-gaap_LitigationSettlementExpense	872,000,000us-gaap_LitigationSettlementExpense	375,000,000us-gaap_LitigationSettlementExpense	529,000,000us-gaap_LitigationSettlementExpense	1,253,000,000us-gaap_LitigationSettlementExpense	2,276,000,000us-gaap_LitigationSettlementExpense	1,218,000,000us-gaap_LitigationSettlementExpense
Cost associated with the DePuy ASR Hip recall program, after tax		111,000,000jnj_RecallCostsAfterTax			118,000,000jnj_RecallCostsAfterTax
Litigation And Recall Expense		126,000,000jnj_LitigationAndRecallExpense			134,000,000jnj_LitigationAndRecallExpense
Gain on sale of assets after tax		1,100,000,000jnj_Gainonsaleofassetsaftertax
Gain (Loss) on Sale of Assets and Asset Impairment Charges		1,900,000,000							2,383,000,000	113,000,000	908,000,000
Other Tax Benefit				(398,000,000)us-gaap_OtherTaxExpenseBenefit	(707,000,000)us-gaap_OtherTaxExpenseBenefit				(400,000,000)us-gaap_OtherTaxExpenseBenefit
Acquisition integration, transaction costs and currency related	325,000,000	167,000,000	144,000,000	118,000,000	181,000,000	122,000,000	122,000,000	258,000,000
research and development after tax	115,000,000jnj_Researchanddevelopmentaftertax				294,000,000jnj_Researchanddevelopmentaftertax	126,000,000jnj_Researchanddevelopmentaftertax
Other Selling and Marketing Expense		220,000,000us-gaap_OtherSellingAndMarketingExpense
In-process research and development	156,000,000us-gaap_ResearchAndDevelopmentInProcess				338,000,000us-gaap_ResearchAndDevelopmentInProcess	178,000,000us-gaap_ResearchAndDevelopmentInProcess			178,000,000us-gaap_ResearchAndDevelopmentInProcess	580,000,000us-gaap_ResearchAndDevelopmentInProcess	1,163,000,000us-gaap_ResearchAndDevelopmentInProcess
Asset Impairment Charges									$ 410,000,000us-gaap_AssetImpairmentCharges	$ 739,000,000us-gaap_AssetImpairmentCharges	$ 2,131,000,000us-gaap_AssetImpairmentCharges